S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-10-01
|
Series: | Lupus Science and Medicine |
_version_ | 1811342158250115072 |
---|---|
author | V Ferré T Papo N Charles A Mageau P Nicaise Roland T Goulenok J Tchen K Sacre |
author_facet | V Ferré T Papo N Charles A Mageau P Nicaise Roland T Goulenok J Tchen K Sacre |
author_sort | V Ferré |
collection | DOAJ |
first_indexed | 2024-04-13T19:06:35Z |
format | Article |
id | doaj.art-051d90c06d984dc3b1bf00e63f86eab9 |
institution | Directory Open Access Journal |
issn | 2053-8790 |
language | English |
last_indexed | 2024-04-13T19:06:35Z |
publishDate | 2022-10-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Lupus Science and Medicine |
spelling | doaj.art-051d90c06d984dc3b1bf00e63f86eab92022-12-22T02:33:57ZengBMJ Publishing GroupLupus Science and Medicine2053-87902022-10-019Suppl 210.1136/lupus-2022-elm2022.11S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus projectV Ferré0T Papo1N Charles2A Mageau3P Nicaise Roland4T Goulenok5J Tchen6K Sacre72Inserm UMR 1137 IAME, service de virologie, hôpital Bichat, AP-HP ~ Paris ~ FranceDepartment of Internal Medicine, Hôpital Bichat-Claude Bernard, Paris6Université de Paris, Centre de Recherche sur l’Inflammation, INSERM UMR1149, CNRS ERL8252, Faculté de Médecine site Bichat, Laboratoire d’Excellence Inflamex ~ Paris ~ France1Inserm UMR 1137 IAME and1149 CRI, service de médecine interne, hôpital Bichat, AP-HP ~ Paris ~ France3Service d’immunologie, hôpital Bichat, AP-HP ~ Paris ~ France5Service de médecine interne, hôpital Bichat, AP-HP ~ Paris ~ France6Université de Paris, Centre de Recherche sur l’Inflammation, INSERM UMR1149, CNRS ERL8252, Faculté de Médecine site Bichat, Laboratoire d’Excellence Inflamex ~ Paris ~ France4Inserm UMR1149 CRI, Service de médecine interne, hôpital Bichat ~ Paris ~ France |
spellingShingle | V Ferré T Papo N Charles A Mageau P Nicaise Roland T Goulenok J Tchen K Sacre S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project Lupus Science and Medicine |
title | S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project |
title_full | S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project |
title_fullStr | S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project |
title_full_unstemmed | S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project |
title_short | S05.1 Efficacy and safety of the anti-SARS-CoV-2 BNT162b2 vaccine among SLE patients: the covalus project |
title_sort | s05 1 efficacy and safety of the anti sars cov 2 bnt162b2 vaccine among sle patients the covalus project |
work_keys_str_mv | AT vferre s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject AT tpapo s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject AT ncharles s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject AT amageau s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject AT pnicaiseroland s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject AT tgoulenok s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject AT jtchen s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject AT ksacre s051efficacyandsafetyoftheantisarscov2bnt162b2vaccineamongslepatientsthecovalusproject |